Today news
The same in other media
Pfizer files for U.S. authorization of its pill to treat COVID-19
Reading now: 621
COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial.Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S.
Food and Drug Administration, including data from the drugmaker’s clinical trial.The oral drug could be promising new weapon in the fight against the pandemic, as it can be taken as an early at-home treatment to help prevent COVID-19 hopitalizations and deaths.
It could also become a important tool in countries and areas with limited access to vaccines or low vaccination rates. New Pfizer COVID-19 pill reduces hospital, death risk by 90%, company says It is not immediately clear when.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|